Shares of Cybin Inc. (OTCMKTS:CLXPF - Get Free Report) traded down 2.5% during trading on Wednesday . The stock traded as low as $9.10 and last traded at $9.29. 503,473 shares changed hands during trading, a decline of 9% from the average session volume of 551,962 shares. The stock had previously closed at $9.53.
Cybin Stock Performance
The company's 50-day moving average is $9.50 and its 200 day moving average is $7.73. The company has a market capitalization of $1.35 billion and a PE ratio of -37.88.
Cybin Company Profile
(
Get Free Report)
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Featured Articles
Before you consider Cybin, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cybin wasn't on the list.
While Cybin currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
